Enfuvirtide is a fusion inhibitor against human immunodeficiency virus. Its mechanism of action is to simulate the HR2 domain of the viral envelope protein gp41, blocking its binding with the HR1 domain, thereby inhibiting the fusion process between the virus and the host cell.